Nigeria’s President Bola Tinubu has appointed Dr. Fatima Zuntu to lead the National Biosafety Management Agency (NBMA), as the country seeks to tighten its regulatory framework around genetically modified organisms (GMOs) and biosecurity.

Dr. Zuntu, a public health professional and policy strategist, takes over as Director-General for an initial four-year term. The appointment, which officially took effect on April 16, comes at a time when Nigeria is increasingly positioning itself as a continental leader in agricultural biotechnology, despite ongoing domestic debates over food safety.

In a statement issued on Monday by the Office of the Secretary to the Government of the Federation, the President tasked Dr. Zuntu with leveraging her expertise in national programmes to safeguard the nation’s health and environment.

A Critical Regulator

The NBMA is the primary “gatekeeper” for biotechnology in West Africa’s largest economy. It is responsible for ensuring that the development, handling, and use of GMOs do not pose risks to human health or the country’s biodiversity.

Key Challenges for the New Director-General:

• GMO Oversight: Balancing the push for food security through biotech with public concerns over genetically modified crops.
• Biosecurity Framework: Strengthening Nigeria’s readiness against biological threats and the regulation of synthetic biology.
• International Standards: Aligning Nigeria’s biosafety protocols with the Cartagena Protocol on Biosafety, an international treaty governing the movement of living modified organisms.

Analysis: Science Meets Strategy

The choice of a “public health professional” over a traditional agricultural scientist to lead the NBMA suggests a shift in the government’s approach. By appointing a policy strategist like Dr. Zuntu, President Tinubu appears to be prioritising the communication and health-impact side of biosafety.

In recent years, Nigeria has approved several genetically modified crops—including cowpea and maize—to boost yields. However, these moves have met with resistance from environmental and consumer rights groups. Dr Zuntu’s “proven track record” in driving national programmes will be put to the test as she attempts to build public trust in the science while maintaining the strict regulatory “policing” role that the NBMA was created to perform.

Implementation and Mandate

The appointment was made in accordance with Section 5 of the National Biosafety Management Agency Act of 2015. Dr. Zuntu is expected to assume her duties immediately at the agency’s headquarters in Abuja.

As the new chief executive, she will oversee a network of laboratories and inspectors tasked with monitoring the country’s borders and research institutions for compliance with biosafety laws. Her first 100 days are likely to focus on an audit of current biotech approvals and a review of the national biosecurity policy.